The bloating that showed up in perimenopause was the thing that blindsided me most. I'd eaten the same way for years, and suddenly I looked six months pregnant by 3pm. Nobody mentioned SIBO. Nobody mentioned that oestrogen dropping could slow the whole digestive conveyor belt down. If your gut feels like it belongs to a stranger right now, this one's worth reading slowly.
Learn more about Rose →Oestrogen receptors are found throughout the gastrointestinal tract, and when oestrogen levels decline in perimenopause, the rhythmic muscular contractions that move food and bacteria through the small intestine — called the migrating motor complex — become less efficient. This slowdown allows bacteria that should be swept into the large intestine to accumulate in the small intestine instead, which is the core mechanism behind SIBO. Research confirms that delayed intestinal transit is one of the strongest risk factors for bacterial overgrowth, making the hormonal slowdown of menopause a direct biological setup.
Progesterone has a well-documented relaxing effect on smooth muscle, which sounds counterintuitive — but in the gut, the right level of progesterone helps regulate the timing of intestinal contractions. As progesterone drops in perimenopause, this regulatory role is disrupted, contributing to irregular bowel patterns and altered transit time. The combination of declining oestrogen and progesterone creates a dual hit to the gut's ability to clear bacteria efficiently from the small intestine.
Both SIBO and menopause independently cause bloating, gas, abdominal discomfort, alternating constipation and diarrhoea, and nausea — which means SIBO in a perimenopausal woman is frequently dismissed as 'just hormones.' This symptom overlap is clinically significant because untreated SIBO worsens nutrient absorption, and its symptoms can be far more severe than typical menopausal gut changes alone. Women whose digestive symptoms feel extreme relative to other menopause symptoms are worth investigating for SIBO as an additional, treatable layer.
Perimenopause is associated with elevated cortisol reactivity, partly because declining oestrogen reduces the buffer oestrogen normally provides against the stress response. Chronically elevated cortisol directly inhibits the migrating motor complex — the intestinal housekeeping wave that clears bacteria between meals — and studies in both human and animal models show that stress-induced motility suppression increases small intestinal bacterial load. This creates a feedback loop where the hormonal stress of perimenopause worsens the gut environment that makes SIBO more likely.
Adequate stomach acid is one of the body's primary defences against bacteria colonising the small intestine — acid kills most organisms before they can travel further down the digestive tract. Oestrogen appears to support gastric acid secretion, and its decline in menopause is associated with a trend toward lower stomach acid output, a condition called hypochlorhydria. When stomach acid is insufficient, bacteria that would normally be neutralised survive and can establish themselves in the small intestine, directly increasing SIBO risk.
Studies using microbiome sequencing show that the gut bacterial community shifts meaningfully after menopause, with reduced diversity and changes in the relative abundance of protective species. A less diverse and robust microbiome in the large intestine may reduce the competitive pressure that normally keeps small intestinal bacteria in check — essentially removing biological competition that would ordinarily limit overgrowth. This postmenopausal microbiome shift is an active area of research, but the pattern is consistent enough across studies to be considered a credible contributing factor.
SIBO damages the brush border of the small intestinal lining and interferes with the absorption of fat-soluble vitamins (D, A, E, K), B12, iron, and calcium — all nutrients that perimenopausal and postmenopausal women are already at elevated risk of being deficient in. This means a woman managing menopause who also has undetected SIBO may find that dietary efforts and supplementation underperform, because absorption itself is compromised. Low vitamin D and calcium in this context carry particular significance given the accelerated bone density loss that accompanies oestrogen decline.
Bacteria in the small intestine produce metabolic byproducts — including hydrogen, methane, and various organic acids — that enter systemic circulation and can cross the blood-brain barrier, influencing neurotransmitter production and neuroinflammation. In a woman already experiencing menopause-related brain fog, mood instability, and fatigue, the additional neurological burden from SIBO bacterial metabolites can make these symptoms significantly worse and harder to attribute. The gut-brain axis is bidirectional and well-established, and SIBO's contribution to cognitive and mood symptoms is increasingly supported by clinical observation.
There is emerging evidence that hormone replacement therapy, by restoring oestrogen levels, may help normalise gut transit time and partially address the motility slowdown that predisposes women to SIBO. However, if SIBO is already established, restoring motility alone is unlikely to resolve the bacterial overgrowth — which generally requires targeted treatment such as specific antibiotic protocols or elemental diet approaches assessed by a clinician. Women on HRT who still experience significant bloating, gas, and digestive irregularity after hormone levels stabilise may benefit from formal SIBO testing, such as a breath test, to determine whether overgrowth is a concurrent issue.
Rose covers every symptom, supplement, and condition in full detail — evidence-graded and agenda-free.
Rose is a free, evidence-based reference built for women navigating perimenopause and menopause. No ads. No products to sell. No agenda. Just honest answers — because every woman in this season deserves a trusted friend who has done the research.